Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes

摘要

Background: The increasing use of mAbs has led to a rise in hypersensitivity reactions (HSRs), which prevent their use as first-line therapy. HSRs' symptoms, diagnostic tools, and directed management approaches have not been standardized.